ArticleBlood cancer discovery2025

DLBCL Cells Emerge after CD19 CAR T Cells with Cross-Antigen Resistance and a Gene Signature Predictive of Clinical CAR T-cell Response.

Fabiana Lüönd et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.